Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Gut

• Publication date

  2012-12-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gutjnl-2011-300777PMID 23263249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009

  2012cited by this paper
• The JAK2 variant rs10758669 in Crohn’s disease: altering the intestinal barrier as one mechanism of action

  2012cited by this paper
• Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives

  2011cited by this paper
• High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

  2011cited by this paper
• The Prognostic Power of the NOD2 Genotype for Complicated Crohn's Disease: A Meta-Analysis

  2011cited by this paper
• Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates

  2010cited by this paper
• NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation

  2010cited by this paper
• Molecular Reclassification of Crohn's Disease by Cluster Analysis of Genetic Variants

  2010cited by this paper
• S04 Identification of a polymorphism that predisposes to longitudinal disease behaviour in Crohn's disease and may have prognostic utility

  2010cited by this paper
• Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

  2010cited by this paper
• The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype

  2010cited by this paper
• Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry

  2010cited by this paper
• Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

  2008cited by this paper
• Predictors of severe Crohn's disease

  2008cited by this paper
• XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.

  2008cited by this paper
• Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort

  2008cited by this paper
• SNPassoc: an R package to perform whole genome association studies

  2007cited by this paper
• A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5.

  2007cited by this paper
• Unravelling the pathogenesis of inflammatory bowel disease

  2007cited by this paper
• Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility

  2007cited by this paper
• Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

  2007cited by this paper
• Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: Results of a Prospective Study

  2006cited by this paper
• The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

  2006cited by this paper
• A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

  2006cited by this paper
• Principal components analysis corrects for stratification in genome-wide association studies

  2006cited by this paper
• Predictors of Crohn's disease.

  2006cited by this paper
• Predictors of Crohn's disease.

  2006cited by this paper
• Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis

  2006cited by this paper
• Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

  2005cited by this paper
• A note on exact tests of Hardy-Weinberg equilibrium.

  2005cited by this paper
• Crohn's Disease Patients Carrying Nod2/CARD15 Gene Variants Have an Increased and Early Need for First Surgery due to Stricturing Disease and Higher Rate of Surgical Recurrence

  2005cited by this paper
• Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.

  2004cited by this paper
• Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis

  2004cited by this paper
• Defining Complex Contributions of NOD2/CARD15 Gene Mutations, Age at Onset, and Tobacco Use On Crohn's Disease Phenotypes

  2003cited by this paper
• The molecular classification of the clinical manifestations of Crohn's disease.

  2002cited by this paper
• CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure.

  2002cited by this paper
• The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

  2002cited by this paper
• Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.

  2002cited by this paper
• Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study.

  2002cited by this paper
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  2001cited by this paper
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

  2001cited by this paper
• Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease

  2001cited by this paper
• Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

  2000cited by this paper

• Perianal Crohn’s Disease in Inflammatory Bowel Disease: Diagnosis, Assessment and Treatment

  2026cites this paper
• Beyond inflammation: what drives the self-perpetuating cycle of fibrosis in IBD?

  2025cites this paper
• The Role of Diet in Crohn’s Disease: From Etiology to Evidence-Based Management

  2025cites this paper
• Macrophage Metabolic Reprogramming in Inflammatory Bowel Diseases: From Pathogenesis to Therapy

  2025cites this paper
• Efficacy of Advanced Therapies in Achieving Remission by Disease Location in Crohn's Disease: A Systematic Review and Meta-analysis.

  2025cites this paper
• The AhR/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects

  2025cites this paper
• MicroRNA Sequencing of Serum Exosomes Reveals miR205-5p as an Anti-Fibrogenic Factor Against Intestinal Fibrosis in Crohn’s Disease

  2025cites this paper
• Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease.

  2025cites this paper
• Documento de posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el manejo de la enfermedad fistulizante no perianal en la enfermedad de Crohn

  2025cites this paper
• Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition

  2025cites this paper
• ACG Clinical Guideline: Management of Crohn's Disease in Adults

  2025influential citation
• Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease

  2025cites this paper
• Management of Perianal Fistulizing Crohn's Disease According to Principles of Wound Repair

  2025cites this paper
• Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial.

  2025cites this paper
• TL1A-activated T cells remodel the rectal mucosa in patients with Crohn’s disease with perianal fistulising disease

  2025cites this paper
• Spanish Working Group in Crohn's Disease and Ulcerative Colitis (GETECCU) position paper for the management of non-perianal fistulizing Crohn’s disease

  2025cites this paper
• Advances in biosensors for diagnosis and monitoring of inflammatory bowel disease: A review

  2025cites this paper
• Roseburia intestinalis‐derived extracellular vesicles ameliorate colitis by modulating intestinal barrier, microbiome, and inflammatory responses

  2024cites this paper
• Identifying the importance of PCK1 in maintaining ileal epithelial barrier integrity in Crohn's disease.

  2024cites this paper
• Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease

  2024influential citation
• Capsule Endoscopy in Inflammatory Bowel Disease: Evolving Role and Recent Advances.

  2024cites this paper
• Recent advances in intestinal fibrosis.

  2024cites this paper
• Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease

  2024cites this paper
• Fibrostenosing Crohn’s Disease: Pathogenetic Mechanisms and New Therapeutic Horizons

  2024cites this paper
• Retrospective Single Nucleotide Polymorphism Analysis of Host Resistance and Susceptibility to Ovine Johne’s Disease Using Restored FFPE DNA

  2024cites this paper
• Post-operative Crohn’s Disease Recurrence and Infectious Complications: A Transcriptomic Analysis

  2024cites this paper
• Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD

  2024influential citation
• Progress in research of TNF-like cytokine 1A as a therapeutic target for inflammatory bowel disease

  2024cites this paper
• Pathogenetic mechanisms of penetrating Crohn’s disease (review)

  2024cites this paper
• The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review

  2024cites this paper
• Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease

  2023cites this paper
• Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease

  2023cites this paper
• A Systematic Review on the Increasing Incidence of Inflammatory Bowel Disease in Southeast Asia: Looking Beyond the Urbanization Phenomenon.

  2023cites this paper
• CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease

  2023cites this paper
• Precision medicine in inflammatory bowel disease

  2023cites this paper
• Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis

  2023cites this paper
• Management of Perianal Fistulizing Crohn's Disease.

  2023cites this paper
• Microbial sensing in the intestine

  2023cites this paper
• Supervised Machine Learning Classifies Inflammatory Bowel Disease Patients by Subtype Using Whole Exome Sequencing Data

  2023cites this paper
• Video Capsule Endoscopy Plays an Important Role in the Management of Crohn’s Disease

  2023cites this paper
• Precision medicine and drug optimization in adult inflammatory bowel disease patients

  2023cites this paper
• Pathogenesis of Perianal Fistulizing Crohn's Disease: Current knowledge, gaps in understanding and future research directions.

  2023cites this paper
• Inflammatory bowel disease–associated intestinal fibrosis

  2023cites this paper
• The genetics of non-monogenic IBD

  2023cites this paper
• Where Are We and Where to Next?—The Future of Perianal Crohn’s Disease Management

  2023cites this paper
• The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence?

  2023cites this paper
• Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway

  2023cites this paper
• Modern Metaproteomics: A Unique Tool to Characterize the Active Microbiome in Health and Diseases, and Pave the Road towards New Biomarkers—Example of Crohn’s Disease and Ulcerative Colitis Flare-Ups

  2022cites this paper
• Offense and Defense in Granulomatous Inflammation Disease

  2022cites this paper
• Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics

  2022cites this paper
• Probing predilection to Crohn's disease and Crohn's disease flares: A crowd-sourced bioinformatics approach

  2022cites this paper
• Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2

  2022cites this paper
• FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease

  2022cites this paper
• Pathogenesis of Fistulating Crohn’s Disease: A Review

  2022cites this paper
• Diagnosis and Classification of Fistula from Inflammatory Bowel Disease and Inflammatory Bowel Disease-Related Surgery.

  2022cites this paper
• Ethnicity influences phenotype and clinical outcomes: Comparing a South American with a North American inflammatory bowel disease cohort

  2022cites this paper
• Newly Diagnosed Crohn’s Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts

  2022cites this paper
• Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea

  2022cites this paper
• Small Bowel Volvulus as Delayed Presentation of Undiagnosed Crohn’s Disease: A Case Report

  2021cites this paper
• Mucosal gene expression profile of stricturing Crohn's disease: A preliminary study.

  2021cites this paper
• The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn’s Disease With Poor Prognostic Factors: The MODIFY Study

  2021cites this paper
• Capsule Endoscopy in Crohn’s Disease—From a Relative Contraindication to Habitual Monitoring Tool

  2021cites this paper
• Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications

  2021cites this paper
• Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology

  2021cites this paper
• Contribution of CD3(+)CD8(-) and CD3(+)CD8(+) T cells to TNF-alpha overexpression in crohn disease-associated perianal fistulas and induction of epithelial-mesenchymal transition in HT-29 cells

  2021cites this paper
• Digestive Tract Disease

  2021cites this paper
• Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review.

  2021cites this paper
• Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study

  2021cites this paper
• Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer

  2021cites this paper
• Paediatric IBD: the host, diet & microbes in pathogenesis & treatment: a narrative review

  2021cites this paper
• Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients.

  2021cites this paper
• Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD - what, why, and how.

  2021cites this paper
• ECCO topical review: Refractory IBD.

  2021cites this paper
• LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages

  2021cites this paper
• Clinical Features and Outcomes of Paediatric Patients With Isolated Colonic Crohn Disease

  2021influential citation
• Crohn’s disease–related single nucleotide polymorphisms are associated with ileal pouch afferent limb stenosis

  2021cites this paper
• Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.

  2021cites this paper
• The Atg16l1 gene: characterization of wild type, knock-in, and knock-out phenotypes in rats

  2021cites this paper
• The Pathogenesis and Clinical Management of Stricturing Crohn Disease.

  2021cites this paper
• A watchful waiting approach for newly diagnosed Crohn’s disease patients with an inflammatory phenotype

  2021cites this paper
• Location is important: differentiation between ileal and colonic Crohn’s disease

  2021cites this paper
• Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease

  2021cites this paper
• Innate Lymphoid Cells in Crohn’s Disease

  2020cites this paper
• Epidemiology and Natural History of Elderly-onset inflammatory bowel disease: Results from a territory-wide Hong Kong IBD registry.

  2020cites this paper
• Fibrotic Strictures in Crohn's Disease: Mechanisms and Predictive Factors.

  2020cites this paper
• Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019

  2020influential citation
• Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn’s disease and active smoking status resulting in ileal stenosis requiring surgery

  2020cites this paper
• Classifying Crohn’s disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification

  2020cites this paper
• Serum biomarkers of fibrostenotic Crohn's disease: Where are we now?

  2020cites this paper
• Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-α Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.

  2020cites this paper
• Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease

  2020cites this paper
• Molecular systems in inflammatory bowel disease

  2020cites this paper
• Precision medicine in inflammatory bowel disease: concept, progress and challenges

  2020cites this paper
• Dysbiosis in a canine model of human fistulizing Crohn’s disease

  2020cites this paper
• Effects of Therapy on Host-Microbe Interactions in Pediatric Inflammatory Bowel Diseases

  2020cites this paper
• Cadherin-11 is a Regulator of Intestinal Fibrosis.

  2020cites this paper
• NOD2 modulates immune tolerance via the GM-CSF–dependent generation of CD103+ dendritic cells

  2020cites this paper
• Crohn's Disease Complicated by Ileosigmoid Fistula - Synchronous Resection or Primary Sigmoid Repair, One or Two-stage Procedure? A systematic review of the literature and prospective case series.

  2020cites this paper
• Luminal Crohn’s Disease

  2019cites this paper
• Fibrosis and Stricturing Disease in Crohn’s Disease

  2019cites this paper